Beginning in July of 2004, we adopted fludarabine and once daily i.v. BU as our standard conditioning regimen for patients undergoing allogeneic HCT. We optimized BU dosing by PK targeting to an ...
Multiple Courses of High-Dose Ifosfamide, Carboplatin, and Etoposide With Peripheral-Blood Progenitor Cells and Filgrastim for Small-Cell Lung Cancer: A Feasibility Study by the European Group for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback